61,104 Shares in Tempus AI, Inc. (NASDAQ:TEM) Bought by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 61,104 shares of the company’s stock, valued at approximately $3,458,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. NEA Management Company LLC purchased a new stake in Tempus AI during the 2nd quarter valued at about $160,048,000. Novo Holdings A S purchased a new stake in shares of Tempus AI during the second quarter valued at approximately $142,605,000. Revolution Growth Management Company Inc. bought a new position in shares of Tempus AI in the second quarter worth approximately $128,133,000. Alphabet Inc. purchased a new position in shares of Tempus AI in the second quarter worth $54,289,000. Finally, Lingotto Investment Management LLP bought a new stake in Tempus AI during the 2nd quarter valued at $32,685,000.

Tempus AI Trading Up 6.2 %

TEM opened at $48.82 on Monday. The company has a quick ratio of 3.52, a current ratio of 3.70 and a debt-to-equity ratio of 4.50. The business has a fifty day moving average price of $51.42. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $77.00.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The company had revenue of $165.97 million for the quarter, compared to the consensus estimate of $159.10 million. Research analysts forecast that Tempus AI, Inc. will post -6.51 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on TEM shares. Morgan Stanley started coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 price objective on the stock. Stifel Nicolaus started coverage on Tempus AI in a research report on Tuesday, July 9th. They set a “buy” rating and a $45.00 price target for the company. Longbow Research began coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price objective on the stock. Needham & Company LLC restated a “buy” rating and set a $47.00 target price on shares of Tempus AI in a report on Wednesday, August 7th. Finally, Bank of America cut shares of Tempus AI from a “buy” rating to a “neutral” rating and lifted their price target for the company from $45.00 to $60.00 in a report on Wednesday, October 2nd. Two research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, Tempus AI presently has an average rating of “Moderate Buy” and a consensus price target of $47.67.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.